Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02)
Status:
Completed
Trial end date:
2006-04-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of an injection of coxsackievirus A21
into a melanoma tumour, and also to see if there is a tumour response.